Bacteriophage Sb-1 enhances antibiotic activity against biofilm, degrades exopolysaccharide matrix and targets persisters of Staphylococcus aureus

International Journal of Antimicrobial Agents

Volumn 52, Issue 6, 2018, Pages 842-853

  Tkhilaishvili, Tamta ^a,b   Lombardi, Lisa ^c   Klatt, Ann Brit ^a,b   Trampuz, Andrej ^a,b   Di Luca, Mariagrazia ^a,b,c,d  

^a BERLIN INSTITUTE OF HEALTH   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c UNIVERSITY OF PISA   (Italy)

^d ISTITUTO NANOSCIENZE CNR   (Italy)

Author keywords

Antibiotic resistance; Antibiotic phage therapy; Bacteriophage; Biofilm; Biofilm matrix degradation; Persister cell; Staggered combination

Indexed keywords

CIPROFLOXACIN; DAPTOMYCIN; EPTIFIBATIDE; EXOPOLYSACCHARIDE; FOSFOMYCIN; PHOSPHATE BUFFERED SALINE; RIFAMPICIN; VANCOMYCIN; ANTIINFECTIVE AGENT; BACTERIAL POLYSACCHARIDE;

ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL GROWTH; BACTERIOPHAGE; BIOFILM; COLONY FORMATION; COLONY FORMING UNIT; CONTROLLED STUDY; DRUG POTENTIATION; DRUG TARGETING; EXTRACELLULAR MATRIX; FLUORESCENCE MICROSCOPY; INHIBITORY CONCENTRATION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; PLANKTON; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; BACTERIAL COUNT; BACTERIOLYSIS; CONFOCAL MICROSCOPY; DRUG EFFECT; GROWTH, DEVELOPMENT AND AGING; METABOLISM; MICROBIAL VIABILITY; STAPHYLOCOCCUS PHAGE; VIROLOGY;

ANTI-BACTERIAL AGENTS; BACTERIOLYSIS; BIOFILMS; COLONY COUNT, MICROBIAL; EXTRACELLULAR MATRIX; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL VIABILITY; MICROSCOPY, CONFOCAL; MICROSCOPY, FLUORESCENCE; POLYSACCHARIDES, BACTERIAL; STAPHYLOCOCCUS PHAGES;

EID: 85056421690     PISSN: 09248579     EISSN: 18727913     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2018.09.006     Document Type: Article

References (40)

1. Zimmerli, W., Trampuz, A., Ochsner, P.E., Prosthetic-joint infections. N Eng J Med 351 (2004), 1645–1654.
2. Boles, B.R., Horswill, A.R., Staphylococcal biofilm disassembly. Trends Microbiol 19 (2011), 449–455.
3. Flemming, H.C., Wingender, J., The biofilm matrix. Nat Rev Microbiol 8 (2010), 623–633.
4. Donlan, R.M., Biofilms: microbial life on surfaces. Emerg Infect Dis 8 (2002), 881–890.
5. Conlon, B.P., Rowe, S.E., Gandt, A.B., Nuxoll, A.S., Donegan, N.P., Zalis, E.A., et al. Persister formation in Staphylococcus aureus is associated with ATP depletion. Nature Microbiol, 1, 2016, 16051.
6. Stewart, P.S., Mechanisms of antibiotic resistance in bacterial biofilms. Int J Med Microbiol 292 (2002), 107–113.
7. Di Luca M, Navari E, Esin S, Menichini M, Barnini S, Trampuz A, et al. Detection of biofilms in biopsies from chronic rhinosinusitis patients: in vitro biofilm forming ability and antimicrobial susceptibility testing in biofilm mode of growth of isolated bacteria. Advances in Experimental Medicine and Biology. Boston, MA: Springer US; 2017. p. 1-28.
8. Schooley, R.T., Biswas, B., Gill, J.J., Hernandez-Morales, A., Lancaster, J., Lessor, L., et al. Development and use of personalized bacteriophage-based therapeutic cocktails to treat a patient with a disseminated resistant Acinetobacter baumannii infection. Antimicrob Agents Chemother, 61, 2017.
9. Torres-Barcelo, C., Hochberg, M.E., Evolutionary Rationale for Phages as Complements of Antibiotics. Trends Microbiol 24 (2016), 249–256.
10. Tkhilaishvili, T., Di Luca, M., Abbandonato, G., Maiolo, E.M., Klatt, A.B., Reuter, M., et al. Real-time assessment of bacteriophage T3-derived antimicrobial activity against planktonic and biofilm-embedded Escherichia coli by isothermal microcalorimetry. Res Microbiol, 2018 pii: S0923-2508(18)30084-6.
11. Kvachadze, L., Balarjishvili, N., Meskhi, T., Tevdoradze, E., Skhirtladze, N., Pataridze, T., et al. Evaluation of lytic activity of staphylococcal bacteriophage Sb-1 against freshly isolated clinical pathogens. Microb Biotechnol 4 (2011), 643–650.
12. Ryan, E.M., Alkawareek, M.Y., Donnelly, R.F., Gilmore, B.F., Synergistic phage-antibiotic combinations for the control of Escherichia coli biofilms in vitro. FEMS Immunol Med Microbiol 65 (2012), 395–398.
13. Chaudhry, W.N., Concepcion-Acevedo, J., Park, T., Andleeb, S., Bull, J.J., Levin, B.R., Synergy and order effects of antibiotics and phages in killing Pseudomonas aeruginosa biofilms. PloS one, 12, 2017, e0168615.
14. Kumaran, D., Taha, M., Yi, Q., Ramirez-Arcos, S., Diallo, J.S., Carli, A., et al. Does treatment order matter? Investigating the ability of bacteriophage to augment antibiotic activity against Staphylococcus aureus biofilms. Front Microbiol, 9, 2018, 127.
15. Adams, M., Enumeration of bacteriophage particles. Bacteriophages, 1959, Interscience Publishers, Ltd, London, 27–34.
16. Rahman, M., Kim, S., Kim, S.M., Seol, S.Y., Kim, J., Characterization of induced Staphylococcus aureus bacteriophage SAP-26 and its anti-biofilm activity with rifampicin. Biofouling 27 (2011), 1087–1093.
17. Alves, D.R., Gaudion, A., Bean, J.E., Perez Esteban, P., Arnot, T.C., Harper, D.R., et al. Combined use of bacteriophage K and a novel bacteriophage to reduce Staphylococcus aureus biofilm formation. Appl Environ Microbiol 80 (2014), 6694–6703.
18. Gonzalez Moreno, M., Trampuz, A., Di Luca, M., Synergistic antibiotic activity against planktonic and biofilm-embedded Streptococcus agalactiae, Streptococcus pyogenes and Streptococcus oralis. J Antimicrob Chemother 72 (2017), 3085–3092.
19. Oliva, A., Furustrand Tafin, U., Maiolo, E.M., Jeddari, S., Bétrisey, B., Trampuz, A., Activities of fosfomycin and rifampin on planktonic and adherent Enterococcus faecalis strains in an experimental foreign-body infection model. Antimicrob Agents Chemother 58 (2014), 1284–1293.
20. Brancatisano, F.L., Maisetta, G., Di Luca, M., Esin, S., Bottai, D., Bizzarri, R., et al. Inhibitory effect of the human liver-derived antimicrobial peptide hepcidin 20 on biofilms of polysaccharide intercellular adhesin (PIA)-positive and PIA-negative strains of Staphylococcus epidermidis. Biofouling 30 (2014), 435–446.
21. Grassi, L., Di Luca, M., Maisetta, G., Rinaldi, A.C., Esin, S., Trampuz, A., et al. Generation of persister cells of Pseudomonas aeruginosa and Staphylococcus aureus by Chemical treatment and evaluation of their susceptibility to membrane-targeting agents. Front Microbiol, 8, 2017, 1917.
22. Costerton, J.W., Stewart, P.S., Greenberg, E.P., Bacterial biofilms: a common cause of persistent infections. Science 284 (1999), 1318–1322.
23. Hauser, A.R., Mecsas, J., Moir, D.T., Beyond antibiotics: new therapeutic approaches for bacterial infections. Clin Infect Dis 63 (2016), 89–95.
24. Harper, D.R., Parracho, H.M.R.T., Walker, J., Sharp, R., Hughes, G., Werthén, M., et al. Bacteriophages and biofilms. Antibiotics 3 (2014), 270–284.
25. Pires, D.P., Melo, L., Vilas Boas, D., Sillankorva, S., Azeredo, J., Phage therapy as an alternative or complementary strategy to prevent and control biofilm-related infections. Curr Opin Microbiol 39 (2017), 48–56.
26. Yilmaz, C., Colak, M., Yilmaz, B.C., Ersoz, G., Kutateladze, M., Gozlugol, M., Bacteriophage therapy in implant-related infections: an experimental study. J Bone Joint Surg Am 95 (2013), 117–125.
27. Sillankorva, S., The use of bacteriophages and bacteriophage-derived enzymes for clinically relevant biofilm control. Borysowski, J, Miedzybrodzki, R, G'orski, A, (eds.) Phage Therapy: Current Research and Applications Norfolk, 2014, Caister Academic Press, UK.
28. Abedon, S., Bacteriophages and biofilms: Ecology, phage therapy, plaques. 2011, Nova Science Publishers, New York.
29. Abedon, S.T., Bacteriophage exploitation of bacterial biofilms: phage preference for less mature targets?. FEMS Microbiol Lett, 363, 2016.
30. Schuch, R., Lee, H.M., Schneider, B.C., Sauve, K.L., Law, C., Khan, B.K., et al. Combination therapy with lysin CF-301 and antibiotic is superior to antibiotic alone for treating methicillin-resistant Staphylococcus aureus–induced murine bacteremia. J Infect Dis 209 (2014), 1469–1478.
31. Vouillamoz, J., Entenza, J.M., Giddey, M., Fischetti, V.A., Moreillon, P., Resch, G., Bactericidal synergism between daptomycin and the phage lysin Cpl-1 in a mouse model of pneumococcal bacteraemia. Int J Antimicrob Agents 42 (2013), 416–421.
32. Bhattacharya, M., Wozniak, D.J., Stoodley, P., Hall-Stoodley, L., Prevention and treatment of Staphylococcus aureus biofilms. Expert Rev Anti Infect Ther 13 (2015), 1499–1516.
33. Trampuz, A., Widmer, A.F., Infections associated with orthopedic implants. Curr Opin Infect Dis 19 (2006), 349–356.
34. Manner, S., Goeres, D.M., Skogman, M., Vuorela, P., Fallarero, A., Prevention of Staphylococcus aureus biofilm formation by antibiotics in 96-microtiter well plates and drip flow reactors: critical factors influencing outcomes. Sci Rep, 7, 2017, 43854.
35. Mihailescu, R., Furustrand Tafin, U., Corvec, S., Oliva, A., Betrisey, B., Borens, O., et al. High activity of fosfomycin and rifampin against methicillin-resistant Staphylococcus aureus biofilm in vitro and in an experimental foreign-body infection model. Antimicrob Agents Chemother 58 (2014), 2547–2553.
36. Levin, B.R., Bull, J.J., Population and evolutionary dynamics of phage therapy. Nature Rev Microbiol 2 (2004), 166–173.
37. Torres‐Barceló C., Franzon, B., Vasse, M., Hochberg, M.E., Long‐term effects of single and combined introductions of antibiotics and bacteriophages on populations of Pseudomonas aeruginosa. Evol Appl 9 (2016), 583–595.
38. Lebeaux, D., Ghigo, J.M., Beloin, C., Biofilm-related infections: bridging the gap between clinical management and fundamental aspects of recalcitrance toward antibiotics. Microbiol Mol Biol Rev 78 (2014), 510–543.
39. Singh, R., Ray, P., Das, A., Sharma, M., Penetration of antibiotics through Staphylococcus aureus and Staphylococcus epidermidis biofilms. J Antimicrob Chemother 65 (2010), 1955–1958.
40. Abedon, S.T., Lysis from without. Bacteriophage 1 (2011), 46–49.